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Purpose: Hypertension and diabetes are known risk factors for retinal microvascular damage. However, the combined
effects of diabetes with early and established stages of hypertension on retinal microvascular degeneration remain
incompletely understood.
Methods: Male spontaneously hypertensive rats (SHR) were compared to SHR with streptozotocin-induced diabetes
(SHR+D) for 6 or 10 weeks and Wistar rats as controls.
Results: Hypertension alone (the SHR group) or in combination with diabetes (the SHR+D group) for 6 weeks induced
additive increases in total retinal cell death, compared to the Wistar controls. This increase was associated with significant
increases in phosphorylated-Jun N-terminal kinase (pJNK) activation, phosphorylated-Akt inhibition, plasma and retinal
lipid peroxides, and soluble intracellular adhesion molecule-1 (sICAM-1) levels. After 10 weeks, a similar trend was still
observed in retinal nitrotyrosine, nuclear factor kappaB p65, and tumor necrosis factor-α expression, associated with
exacerbated pJNK activation and formation of acellular capillaries.
Conclusions: In conclusion, combining diabetes and hypertension-potentiated retinal oxidative/inflammatory stress
promoted imbalance between the JNK stress and survival Akt pathways resulting in accelerated retinal cell death and
acellular capillary formation.
Hypertension has been identified as an independent risk
factor for developing retinopathy. The results of the Beaver
Dam Eye 15-year cumulative study in non-diabetic subjects
showed that uncontrolled blood pressure is associated with
increased  incidence  of  retinopathy  [1].  Early  phases  of
hypertensive  retinopathy  are  characterized  by  increased
retinal  microvascular  changes,  highlighted  by  generalized
retinal arteriolar narrowing due to increased vascular tone
[2].  However,  the  exact  mechanism  behind  hypertensive
retinopathy is not fully understood. Several mechanisms have
been proposed, including oxidative stress [3], inflammation
[4], and resulting endothelial dysfunction [5].
Diabetic  retinopathy  is  the  second  major  cause  of
blindness  in  working  adults  in  the  United  States  [6].
Accelerated death of retinal capillary cells leading to vaso-
obliteration  and  acellular-occluded  capillaries  are  well
defined histopathological changes of diabetic retinopathy in
clinical and experimental models [7-9]. We and others have
previously  established  diabetes-induced  peroxynitrite
formation  and  inflammation  as  the  major  molecular
mechanisms responsible for retinal endothelial dysfunction
and vascular cell death [10-18].
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Diabetes  and  hypertension  are  common  comorbid
conditions  that  have  been  identified  as  independent  risk
factors for the development of endothelial dysfunction [19,
20]. Clinical evidence indicates a beneficial effect of lowering
blood  pressure  on  the  progression  of  diabetic  retinopathy
[21-23]. However, the effects of early and established stages
of hypertension combined with diabetes on the development
of  retinopathy  and  possible  contribution  to  retinal
microvascular degeneration remain incompletely understood.
The aim of the current study was to examine the effects of
early and established hypertension alone or in combination
with diabetes—as known risk factors for vascular damage—
on  development  of  retinopathy  and  retinal  microvascular
degeneration. Our results identify key molecular mechanisms
involved such as imbalance between the stress Jun N-terminal
kinase  (JNK)  and  survival  protein  kinase  B  (PKB/Akt)
pathways  and  increased  systemic  and  retinal  oxidative/
inflammatory stress, resulting in increased retinal cell death
and exacerbated acellular capillary formation.
METHODS
Animal preparation: All of the animal studies were conducted
in accordance with the Association for Research in Vision and
Ophthalmology (ARVO) Statement for the Use of Animals in
Ophthalmic and Vision Research and the Charlie Norwood
Veterans’  Affairs  Medical  Center  Animal  Care  and  Use
Committee. Six-week-old male spontaneously hypertensive
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1457rats (SHR) were randomly assigned to an SHR or diabetic
SHR (SHR+D) group. Normal Wistar Kyoto (W) rats served
as control. Diabetes was induced in the SHR by a single
intravenous  injection  of  streptozotocin  (STZ,  60  mg/kg).
Detection of glucose in urine and blood glucose levels >13.9
mmol/l  indicated  diabetes.  Rats  were  supplemented  with
insulin pellets (subcutaneously) to prevent ketoacidosis. Rats
were weighed weekly, and blood glucose measurements were
taken from a tail vein using a glucometer. As shown in (Table
1), animals injected with STZ had significant increases in
blood glucose levels and decreases in bodyweight compared
with the control W group and the SHR group. Animal groups
were  deeply  anesthetized  for  terminal  sacrifice  using
intraperitoneal  injection  of  ketamine/xylazine  mixture
(48  mg/kg  and  6.4  mg/kg,  respectively;  Phoenix
Pharmaceuticals, St. Joseph, MO) after 6 or 10 weeks of
diabetes induction.
Evaluation of cell death in rat retina: Quantitative cell death
was  assessed  with  terminal  deoxynucleotidyl  transferase
dUTP  nick-end  labeling  (TUNEL)  assay  in  flatmounted
retinas  using  immunoperoxidase  staining  (ApopTag-
Peroxidase;  Millipore  Corporation,  Billerica,  MA),  as
described previously by our group [24]. Briefly, whole, flat-
mounted  samples  were  stained  with  3-amino-9-
ethylcarbazole  (Sigma,  St.  Louis,  MO)  following  the
manufacturer’s instructions. The total number of TUNEL-
positive cells per retina was counted using light microscopy.
Appropriate negative and positive controls were used to assess
proper reactivity.
Detection  of  lipid  peroxides:  Levels  of  lipid  peroxides
(malondialdehyde, MDA) were assayed using thiobarbituric
acid reactive substances (TBARS) as described before by our
group  [24].  Briefly,  plasma  or  retinal  homogenate  were
acidified with 20% acetic acid, 8% sodium dodecyl sulfate,
and thiobarbituric acid at 95 °C for 60 min, and then the
reaction  was  cooled  down  on  ice.  The  samples  were
centrifuged, the supernatant was extracted with n-butanol and
pyridine  (15:1,  respectively),  and  the  absorbance  of  the
organic solvent layer was measured colorimetrically at 532
nm.  The  results  were  compared  to  an  external  standard
(tetramethoxypropane).  The  Bradford  assay  (Bio-Rad,
Hercules, CA) was also performed to determine the protein
concentration of the retinal lysate. The lipid peroxide level
was expressed in µM MDA/mg total protein.
Detection  of  systemic  soluble  intracellular  adhesion
molecule-1: Plasma soluble intracellular adhesion molecule-1
(sICAM-1) levels were measured as an indicator of systemic
inflammation using the quantitative sandwich enzyme-linked
immunoassay  (ELISA)  technique  (R&D  systems,
Minneapolis, MN). Briefly, plasma samples from all groups
were  pipetted  into  microplate  wells  precoated  with  a
monoclonal antibody specific for rat sICAM-1. The color
produced after an enzyme-linked polyclonal antibody was
added was specific for rat sICAM-1, and the substrate solution
was measured colorimetrically at 450 nm.
Detection  of  retinal  peroxynitrite  formation:  Slot-blot
analysis was used to indirectly measure peroxynitrite levels
with its footprint nitrotyrosine (NY). As described previously
[24],  5  μg  of  retinal  homogenate  from  rat  samples  were
immobilized onto a nitrocellulose membrane. After blocking,
the membrane was reacted with antinitrotyrosine polyclonal
antibody  (Calbiochem,  Millipore)  followed  by  its  relative
secondary  antibody,  and  the  optical  densities  of  various
samples were compared to those of the controls [24].
Western  blot  analysis:  Retinas  were  lysed  in  modified
radioimmunoprecipitation  assay  (RIPA)  buffer  (Millipore,
Billerica, MA) for 30 min on ice. Insoluble material was
removed by centrifugation at 14,000× g at 4 °C for 30 min.
About 30–50 µg of total protein were boiled in 6× Laemmli
sample  buffer,  separated  on  a  10%–12%  sodium  dodecyl
sulfate–polyacrylamide gel by electrophoresis, transferred to
nitrocellulose  membranes,  and  then  reacted  with  specific
primary and secondary antibodies respectively. The primary
antibodies  for  Akt,  phosphorylated-Akt  (pAkt),  c-JNKs,
phosphorylated-JNKs (pJNKs), total nuclear factor kappaB
(NFκB)  p65  (all  from  Cell  signaling,  Danvers,  MA),  and
TABLE 1. EFFECTS OF STZ-INDUCED DIABETES ON BODYWEIGHT AND BLOOD GLUCOSE LEVELS IN RAT GROUPS.
Group n End weight (g) End blood glucose mmoles/l
6-weeks
W 12 316±9 6.9±0.4
SHR 12 314±7 6.5±0.37
SHR+D 12 265±13* 27±3*
10-weeks
W 6 380±8 7.7±0.8
SHR 6 372±7 8±0.5
SHR+D 6 248±13* 28.7±3*
        Rats were rendered diabetic by a single streptozotocin injection (60 mg/kg) in freshly prepared 10 mmol/l sodium citrate buffer,
        pH 4.5. Data are mean±SEM *Significant difference versus other groups at p<0.05.
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1458tumor necrosis factor-α (TNF-α; Novus Biologicals, Littleton,
CO) were used and detected using a horseradish peroxidase-
conjugated  antibody  and  enhanced  chemiluminescence
(Thermoscientific, Rockford, IL). Nitrocellulose membranes
were  subsequently  scanned,  and  band  intensities  were
quantified using (Alpa Innotech, Protein simple, Santa Clara,
CA) imaging and densitometry software.
Isolation of retinal vasculature: Retinal vasculatures were
isolated  as  described  previously  [25].  Briefly,  freshly
enucleated  eyes  were  fixed  with  2%  paraformaldehyde
overnight. Retina cups were dissected, washed in phosphate-
buffered saline, and then incubated with 3% Difco-Trypsin
250 (BD Biosciences, San Jose, CA) in 25 mM Tris buffer,
pH 8, at 37 °C for 2 h. Vitreous and nonvascular cells were
gently removed from the vasculature. The vasculature was
then soaked in several washes of 5% Triton X-100 to get rid
of the neural retina. The transparent vasculature was laid out
on slides and used for acellular capillary examination.
Determination of degenerated (acellular) capillaries: Retinal
vasculature sections were stained with periodic acid-Schiff
and hematoxylin (PASH). Acellular capillary counts were
Figure 1. Early stage hypertension and diabetes exacerbates retinal
cell death. A: Flat-mounted retinal samples showing increased total
retinal cell death, as indicated with TUNEL-positive nuclei using
immunoperoxidase staining, in early stage spontaneous hypertensive
rats  (SHR)  which  was  exacerbated  in  diabetic  spontaneous
hypertensive rats (SHR+D) compared to control wistar group (W).
B:  Statistical  analysis  of  the  number  of  TUNEL-positive  cells
showed a 4.7 fold (64.4±2.8) increase in the number of apoptotic cells
in the SHR alone group and 10.6 fold (142.6±16.3) increase in the
combined SHR+D group when compared to the W control group
(13.5±2; n=5–7, *p<0.001). There was also a 5.8 fold significant
difference between the SHR+D and SHR groups (#p=0.002).
quantified under microscope (400×) in a masked manner.
Acellular capillaries were identified as capillary-sized blood
vessel tubes having no nuclei anywhere along their length.
The number of acellular capillaries were counted in eight
different fields of the mid-retina and then averaged together,
indicating the number/high power field of each image.
Data  analysis:  Results  were  expressed  as  mean±standard
error of the mean (SEM). Differences among experimental
groups were evaluated with ANOVA, and the significance of
differences between groups was assessed with the post hoc
test  (Fisher’s  protected  least  significant  difference)  when
indicated. Significance was defined as p<0.05.
RESULTS
Early stage hypertension induces and diabetes exacerbates
retinal cell death: Apoptosis begins early in diabetes and
likely  contributes  to  neuronal  death  and  later  capillary
obliteration,  which  are  important  features  of  retinopathy
[26-28].  Here,  we  examined  whether  early  stages  of
hypertension  alone  or  combined  with  diabetes  can  cause
retinal  cell  death.  After  the  rats  underwent  6  weeks  of
hypertension  with  or  without  diabetes,  quantitative
assessment of retinal cell death in the flatmounted retinas
showed that the SHR alone group had a 4.7-fold increase in
the total number of TUNEL positive nuclei/retina that was
Figure 2. Early stage hypertension and diabetes stimulate activation
of  the  Jun  N-terminal  kinase  (JNK)  stress  pathway.  A:
Representative  image  for  western  blot  analysis  of  retinal
phosphorylated- pJNK protein expression in early stage spontaneous
hypertensive rats (SHR) and diabetic spontaneous hypertensive rats
(SHR+D)  compared  to  control  wistar  group  (W).  B:  Statistical
analysis showing that activation of pJNK was 1.75 fold higher in the
SHR group that was increased to 1.9 fold in the combined SHR+D
group relative to the control W group (n=3-4, * p<0.05).
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compared to the W control group (Figure 1A,B).
Early stage hypertension and diabetes stimulate activation of
Jun N-terminal kinase stress pathway: We sought to assess
whether this early increase in retinal cell death was a result of
activation of stress pathways. The SHR alone and combined
SHR+D groups induced phosphorylation of the stress JNK
protein 1.7 and 1.9 fold, respectively, relative to the control
W group (Figure 2A,B).
Early stage hypertension and diabetes impair Akt survival
pathway: In addition, activation of the JNK stress pathway
was mirrored by the inhibition of the Akt survival pathway.
Akt protein phosphorylation was inhibited 0.5-fold in the SHR
group and 0.7 fold in the combined SHR+D group relative to
the control W group (Figure 3A,B).
Early stage hypertension causes and diabetes exacerbates
oxidative stress and inflammation: Hypertension and diabetes
are  known  pro-oxidative  stress  and  proinflammatory
conditions. Therefore, we examined plasma and retinal lipid
peroxide and plasma sICAM-1 levels as markers of oxidative
and inflammatory stress. The plasma and retinal lipid peroxide
levels increased 4.5 and 1.4 fold in the SHR alone group
whereas the combined SHR+D group levels were higher by
6.5 and 1.7 fold, respectively, compared to the control W
group (Figure 4A,B). In parallel, an 1.25 fold increase in
Figure 3. Early stage hypertension and diabetes suppress the Akt
survival pathway. A: Representative image for western blot analysis
of retinal phosphorylated-AKt (AKt) protein expression in early
stage spontaneous hypertensive rats (SHR) and diabetic spontaneous
hypertensive rats (SHR+D) compared to control wistar group (W).
B: Statistical analysis showing that activation of pAkt was inhibited
by 0.5 fold in the SHR group that was increased to 0.7 fold in the
combined SHR+D group relative to the control W group (n=3-4,
*p<0.05).
plasma sICAM-1 levels was also detected in the SHR alone
Figure 4. Early stage hypertension and diabetes exacerbate oxidative
stress  and  inflammation.  A:  Plasma  thiobarbituric  acid  reactive
substances  (TBARS)  levels  were  higher  in  the  spontaneously
hypertensive  rats  (SHR)  alone  group  by  4.5  fold,  whereas  the
combined diabetic spontaneous hypertensive rats (SHR+D) group
plasma levels were higher by 6.5 fold when compared to control W
group (n=6, *p<0.05). There was a 1.53 fold difference in plasma
TBARS levels between the SHR+D and SHR groups (#p<0.05). B:
Retinal lipid peroxides were higher in the SHR group by 1.43 fold
and in the SHR+D group by 1.69 fold (n=4, *p<0.05). C: Plasma
sICAM-1 were higher in the SHR alone group by 1.25 fold and in
the combined SHR+D group by 1.9 fold when compared to control
W group (n=6, *p<0.05). There was also a 0.65 fold difference in
sICAM-1  plasma  levels  between  the  SHR+D  and  SHR  groups
(p<0.05).
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when compared to the control W group (Figure 4C).
Established hypertension and diabetes maintain exacerbated
retinal nitrative stress: We next examined the effects of later
stage hypertension with or without diabetes (after 10 weeks
of duration). A similar trend of increased oxidative stress was
still  observed  through  increased  levels  of  retinal  NY,  the
footprint  for  peroxynitrite,  implicating  retinal  endothelial
dysfunction [13]. Retinal NY levels in the SHR alone group
increased 1.98 fold and 4.1 fold in the SHR+D group relative
to the control W group (Figure 5A,B).
Established hypertension and diabetes maintain exacerbated
retinal inflammation: Similarly, late stage hypertension with
or without diabetes also sustained in retinal inflammation
evidenced by increased NFκB p65 protein expression. Retinal
inflammation was 1.76 and twofold higher in the SHR alone
and SHR+D groups, respectively, relative to the control W
group  (Figure  6A,B).  NFκB  is  known  to  induce  the
transcription  of  different  proinflammatory  cytokines,
including TNF-α, which is essential for inducing apoptosis in
retinal neuronal and endothelial cells [29]. TNF-α protein
expression was 3.4 fold higher in the SHR alone group relative
to the control W group, and increased 5.4 fold in the combined
SHR+D group (Figure 6C,D).
Established hypertension maintains and diabetes exacerbates
activation of Jun N-terminal kinase stress pathway: As shown
in (Figure 7A,B), activation of the JNK stress pathway was
Figure 5. Established hypertension alone or in combination with
diabetes  stimulates  retinal  peroxynitrite  formation.  A:
Representative image shows slot blot analysis of retinal nitrotyrosine
(NY) levels in various groups. B: Retinal NY levels were higher in
the SHR and SHR+D groups by 1.98 fold and 4.1 fold, respectively,
relative to the control W group (n=4, *p<0.05).
further exacerbated at 10 weeks 3 and 8.35 fold in the SHR
and  combined  SHR+D  groups,  respectively.  We  next
evaluated  activation  of  the  survival  pathway  Akt.  Results
showed  a  trend  toward  decreased  expression  of  total  Akt
levels and decreased Akt phosphorylation in the SHR alone
and SHR+D groups yet did not reach statistical significance
in either group (Figure 7C,D).
Established hypertension causes and diabetes exacerbates
retinal  vascular  degeneration:  We  finally  evaluated  the
effects of 10 weeks of hypertension alone or in combination
with  diabetes  on  retinal  microvascular  degeneration,  the
hallmark of retinopathy, as assessed by acellular capillary
formation. Retinal tryptic digests stained with periodic acid-
Schiff and hematoxylin showed higher numbers of acellular
capillaries in the SHR group by 2.8 fold that was exacerbated
in the SHR+D group to 5.64 fold relative to the control W
group (Figure 8A,B).
DISCUSSION
There  is  growing  evidence  supporting  the  notion  that
endothelial dysfunction and inflammation are common events
driving  the  development  of  various  retinal  microvascular
changes in patients with hypertension, diabetes, and other
metabolic disorders [30,31]. However, the synergistic impact
of these commonly coexisting conditions on the development
of retinopathy has not been fully elucidated. Our current study
aimed to model the early and established detrimental effects
of combining hypertension with diabetes on the development
of retinopathy and retinal microvascular degeneration using
diabetic  spontaneously  hypertensive  rats,  an  established
model for studying hypertension.
Clinical evidence highlights the role of oxidative stress
and  endothelial  dysfunction  as  previously  indicated  by
increased levels of lipid peroxidation and platelet activation
in patients with hypertension-related microvascular changes
when compared with patients with or without early signs of
retinopathy  [3,30].  Our  results  showed  the  SHR  group
demonstrated  significant  increases  in  systemic  and  retinal
lipid peroxides as early as 6 weeks of hypertension, which was
maintained through increased retinal NY levels, the footprint
of peroxynitrite, at 10 weeks. In fact, our previous studies
established NY as a legitimate marker for retinal endothelial
dysfunction as a result of endothelial nitric oxide synthase
uncoupling and decreased bioavailability of nitric oxide [13,
14].  These  findings  lend  further  support  to  other  studies
showing increased oxidative stress and nitrotyrosine levels in
prehypertensive SHR [32,33].
Inflammation has been proposed as an essential partner
for  oxidative  stress  in  the  development  of  hypertensive
retinopathy  [5,34].  Our  data  demonstrated  a  significant
increase in the plasma sICAM-1 levels in the early stage of
hypertension and a significant upregulation of the NFκB p65/
TNF-α pathway in the established stage. In accordance, an
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reactive  protein,  a  marker  of  systemic  low-grade
inflammation, and the extent of microvascular complications
in  hypertensive  patients  was  clinically  observed  [4].  In
addition,  a  previous  report  has  also  shown  a  significant
increase in NFκB p65 expression in prehypertensive SHR and
a trend toward the upregulation of retinal ICAM-1 expression
and macrophage infiltration in established hypertensive rats
that did not reach statistical significance [34].
Hypertension frequently coexists with diabetes [19,20].
Major clinical studies such as the UK Prospective Diabetes
Study Group and others have shown beneficial effects of tight
blood pressure control and antihypertensive renin-angiotensin
system blockers on prevention and progression of retinopathy
in diabetic patients [22,35,36]. Therefore, we examined the
combined effects of diabetes on hypertension on observed
levels  of  oxidative  stress  and  inflammation.  Our  results
demonstrated  that  the  combined  SHR+D  group  had
exacerbated oxidative stress and inflammation at early stage
and established levels, as indicated by increased systemic and
retinal lipid peroxide, plasma sICAM, retinal NY, NFκB p65,
and TNF-α levels. In line with our findings, a similar cohort
of studies by Lopes de Faria et al. [32,34] has also shown
additive  increases  in  superoxide  anion  production,  NY
formation,  in  addition  to  higher  NFκB  p65  and  ICAM-1
expression,  resulting  in  increased  retinal  macrophage
infiltration in prehypertensive and hypertensive diabetic SHR,
respectively. Most of the aggravating effects of diabetes on
hypertensive  retinas  were  corrected  by  reestablishing  the
redox  balanced  state  and  inducible  nitric  oxide  synthase
suppression  using  an  exogenous  superoxide  dismutase
mimetic  [33]  or  angiotensin  receptor  blocker  [37,38],
indicating the convergence between hyperglycemia and the
rennin-angiotensin system on oxidative stress pathways that
may also lead to associated increases in inflammation.
In response to diabetes, apoptosis of retinal neuroglial
cells begins as early as 4 weeks [26] and likely contributes to
neuroglial inflammation culminating in capillary obliteration,
retinopathy lesions, and increased formation of non-perfused
acellular  capillaries  [7,27,28].  In  agreement,  our  results
showed  that  hypertension  alone  or  in  combination  with
diabetes accelerated retinal cell death as indicated by TUNEL-
positive cells as early as 6 weeks of duration. The majority of
apoptotic cells may be of neuronal origin at that time point
[26]. In addition, Lopes de Faria et al. have shown increased
total retinal DNA damage after 3 weeks of hypertension only
or combined with diabetes [34,38] and exacerbated levels of
Figure 6. Established hypertension alone or in combination with diabetes stimulates retinal inflammation. A: Representative image for western
blot analysis of retinal nuclear factor kappaB p65 (NFkB p65) protein expression in the established stage of spontaneous hypertensive rats
(SHR) and diabetic spontaneous hypertensive rats (SHR+D) compared to control wistar group (W). B: Representative image for western blot
analysis of retinal tumor necrosis factor aplha (TNF-α) protein expression in the established stage of SHR and SHR+D compared to control
wistar group (W; n=4, *p<0.05). C: Representative image shows results of western blot analysis of retinal TNF-α protein expression. D:
Statistical analysis showed that TNF-α protein expression was higher in the SHR and SHR+D groups by 3.4 and 5.4 fold, respectively, relative
to the control W group (n=4, *p<0.05).
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in neuronal and glial cells after 12 weeks [37].
Retinal oxidative/nitrative and inflammatory stress has
been  closely  associated  with  activation  of  p38  and  JNK–
mitogen-activated  protein  kinases,  resulting  in  apoptosis
[10,12,39].  Here,  we  report  that  early  stage  hypertension
(SHR)  activated  JNK  phosphorylation  after  just  6  weeks
compared to the W controls. These effects were paralleled
with a reduction in the activation of the Akt survival pathway.
Combining hypertension with diabetes (SHR+D) increased
JNK  activation  and  further  impaired  Akt  phosphorylation
compared to the W control group. Moreover, JNK activation
was further exacerbated at 10 weeks in addition to maintaining
the trend toward impaired expression and activation of Akt.
Despite previous observations that significant increases in
acellular  capillary  formation  are  usually  observed  after  6
months of diabetes [8,40,41], interestingly, the observed JNK/
Akt  imbalance  coincided  with  significant  increases  in
acellular capillary formation in the SHR alone group or in
combination with diabetes at 10 weeks (Figure 8). Retinal
microvascular cell death can occur as a result of increased
leukostasis, direct biochemical insults within microvascular
cells, or indirectly by neuroglial cells (reviewed in [27]). One
of the limitations of our current study is that we did not dissect
whether  the  observed  imbalance  between  JNK  and  Akt
pathways  and  resulting  increases  in  apoptosis  occurred
predominantly in microvascular cells. Hence, further studies
are  warranted  for  such  investigations.  Nevertheless,  the
proapoptotic role of JNK activation has been demonstrated in
inducing total retinal, pericyte, and microvascular cell death
in vivo and in vitro [39,42-44]. We have also previously
demonstrated a role for oxidative stress in altering the Akt/
p38 MAP kinase balance, hence promoting endothelial cell
death via peroxynitrite-mediated PI3-kinase tyrosine nitration
in models of hyperglycemia and ischemic retinopathy [12,
45]. Accelerated retinal capillary dropout, vascular tortuosity,
and vascular leakage were previously reported in obese SHR
starting at 12 weeks of age, which became more striking at 10
months [46]. Another group has also showed aggravation of
the  number  of  acellular  capillaries  and  arteriolar
microthromboses in SHR+D compared to diabetic W rats,
which was mitigated by treatment with aminoguanidine, an
advanced glycation product formation inhibitor, but after 26
weeks of diabetes [47]. Of note, to the best of our knowledge,
we are the first group to report an imbalance between the
Figure 7. Established hypertension alone or in combination with diabetes stimulates JNK stress pathway and impairs the survival Akt pathway.
A: Representative image for western blot analysis of retinal phosphorylated-Jun N-terminal kinase (pJNK) protein expression in the established
stage of spontaneous hypertensive rats (SHR) and diabetic spontaneous hypertensive rats (SHR+D) compared to control wistar group (W).
B: Statistical analysis showed that activation of pJNK was higher by threefold in the SHR group that was increased to 8.35 fold in the combined
SHR+D group relative to the control W group (n=3, *p<0.05). C: Representative image for western blot analysis of retinal phosphorylated-
AKt (AKt) protein expression in the established stage of SHR and SHR+D compared to W. D: Statistical analysis showing that activation of
pAkt tends to be inhibited by 0.3 fold in the SHR group and 0.4 fold in the combined SHR+D group relative to the control W group (n=3,
p=0.19 and 0.26, respectively).
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alone model or in its combination with diabetes in vivo.
In summary, these results suggest potentiating effects
between systemic hypertension and diabetes as independent
risk factors for retinopathy. This emphasizes the importance
of addressing different cardiovascular risk factors in a holistic
approach  for  improving  management  and  prevention  of
retinopathy.  Further  studies  are  warranted  to  screen  the
protective effects of inhibiting JNK stress pathway activation
and  restoring  Akt  survival  signals  in  the  development  of
retinopathy in hypertension with or without diabetes and to
dissect  their  causative  role  in  retinal  microvascular
degeneration.
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